血栓管理设备市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)

推动血栓管理设备增长的关键因素包括心血管疾病的增加、人口老龄化以及意识的提高导致血栓管理设备的使用增加。

根据世界卫生组织 (WHO) 的数据，心血管疾病每年在全球造成 1790 万人死亡。 此外，中风和心脏病发作的患病率增加以及对治疗血栓的微创手术的需求不断增长预计将推动市场增长。

此外，血栓管理技术的进步以及公司为创新血栓管理治疗方法所做的努力进一步推动了市场的增长。 然而，严格的监管政策和替代疗法的可用性预计会阻碍市场增长。

血栓管理设备的市场趋势

神经血管栓塞有望显着增长

• 由于研发投资的增加和产品技术的持续创新，神经血管栓塞有望实现显着增长。
• 此外，对微创手术的需求不断增加以及患者对这些治疗的认识不断提高预计将推动该细分市场的增长。
• 根据世界卫生组织 (WHO) 的数据，患有深静脉血栓形成 (DVT) 和肺栓塞 (PE) 的人数远远超过患有艾滋病和癌症的人数。 2015 年，美国约有 900 万人被诊断出患有 DVT 和 PE。
• 此外，髋关节、膝关节和脊柱手术（这些都是中风的高危因素）的增加预计将推动中风相关导管引导溶栓市场的发展。 此外，久坐不动的生活方式和不健康的饮食导致肥胖和其他静脉相关疾病也有望在预测期内推动市场增长。

预计北美将占据较大的市场份额

由于有利的报销政策和完善的医疗保健基础设施的可用性，预计在预测期内北美将获得很大的市场份额。 此外，心脏病患者的负担和具有更好临床结果的设备的技术进步正在推动美国的市场增长。 根据美国疾病控制与预防中心 (CDC) 的数据，截至 2019 年，美国估计有 795,000 人中风。 其中，610,000 人患有首次中风或新中风。 此外，仅在美国，中风每年就花费 340 亿美元。

由于医疗保健基础设施的改善、城市化带来的久坐不动的生活方式以及该地区中风负担增加等因素，预计亚太地区在预测期内将呈现显着的增长率。 此外，更高的患者数量预计会增加医疗支出，预计这将推动预测期内的增长。

血栓管理器械市场竞争分析

血栓管理设备的全球市场适度整合且竞争激烈。 市场参与者正专注于产品创新、新产品发布和区域扩张，以增加市场份额。 在血栓管理设备市场运营的主要市场参与者包括美敦力公司、波士顿科学公司、Edward Lifesciences、AngioDynamics, Inc、LeMaitre Vascular, Inc。

其他好处

• Excel 格式的市场预测 (ME) 表
• 三个月的分析师支持

内容

第一章介绍

• 调查结果
• 调查假设
• 本次调查的范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

• 市场概览
• 市场驱动因素
  • 心血管疾病患病率和人口老龄化
  • 对微创手术和技术进步的需求不断增加
• 市场製约因素
  • 严格的监管程序
  • 替代疗法的可用性
• 波特的五力分析
  • 新进入者的威胁
  • 买方/消费者议价能力
  • 供应商的议价能力
  • 替代品的威胁
  • 竞争公司之间的敌对关係

第 5 章市场细分

• 按产品分类
  • 取栓导管
  • 导管引导溶栓装置
  • 经皮取栓装置
  • 下腔静脉滤器
  • 神经血管栓塞装置
• 最终用户
  • 医院
  • 门诊手术中心
  • 其他
• 按地区
  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳大利亚
    • 韩国
    • 其他亚太地区
  • 中东和非洲
    • 海湾合作委员会
    • 南非
    • 其他中东和非洲地区
  • 南美洲地区
    • 巴西
    • 阿根廷
    • 其他南美洲

第六章竞争格局

• 公司简介
  • Medtronic Plc
  • Boston Scientific Corporation
  • Edward Lifesciences
  • Teleflex Incorporated
  • Johnson & Johnson
  • LeMaitre Vascular, Inc.
  • Strub Medical GmbH & Co. KG
  • AngioDynamics
  • iVascular SLU
  • Cook Group Incorporated

第7章 市场机会今后动向

The key driving factors for the growth of clot management devices include increasing prevalence of cardiovascular diseases, rise in geriatric population and growing awareness which is leading to increased use of clot management devices. According to the World Health Organization (WHO), cardiovascular diseases cause 17.9 million deaths each year worldwide. Furthermore, increasing prevalence of stroke and heart attack, growing demand for minimally invasive procedures in the treatment of blood clots is expected to bolster the market growth.

In addition, advances in clot management technologies and efforts of the companies in innovating the treatments for blood clot management are further fuelling the market growth. However, stringent regulatory policies and availability of alternative treatments are expected to hamper the market growth.

Clot Management Devices Market Trends

Neurovascular Embolectomy is Expected to Register Significant Growth

• Neurovascular embolectomy projected to have significant growth rate owing to increasing R&D investments and continuous innovations in product technologies.
• Furthermore, growing demand for minimally invasive procedures coupled with rising awareness in patients regarding these treatments is expected to fuel the segment growth.
• According to the World Health Organization (WHO), the number of people suffering from deep vein thrombosis (DVT) and pulmonary embolism (PE) is much larger than people suffering from AIDS, and Cancer. During the year 2015, around 9,00,000 people were diagnosed by DVT & PE in United States.
• Furthermore, rise in hip, knee and spinal surgeries which are high-risk factors for stroke are expected to boost the stroke-related catheter-directed thrombolysis market. Moreover, sedentary lifestyle and unhealthy food habits leading to obesity and other vein related diseases expected to boost the market growth over the forecast period.

North America is Expected to have Significant Market Share

North America is projected to have significant market share over the forecast period owing to favourable reimbursement policies and availability of well-established healthcare infrastructure. In addition, the burden of cardiac patients and technological advancements in devices to produce better clinical outcomes are driving the market growth in United States. According to the Center for Disease Control (CDC), approximately, 795,000 people in the United Sstates are having stroke as of 2019. Of these, 610,000 are first or new strokes. Furthermore, stroke annually costs 34 billion in United States alone.

The Asia Pacific region is projected to have notable growth rate over the forecast period owing to the factors such as improving healthcare infrastructure, urbanization leading to the sedentary lifestyle and growing burden of stroke in the region. Moreover, a large patient pool growing healthcare spending in the region expected to bolster the regional growth over the forecast period.

Clot Management Devices Market Competitive Analysis

Global clot management devices market is moderately consolidated and competitive. Market players are focusing on product innovations, new product launches and regional expansions to increase their market share. The key market players operating in clot management devices market include Medtronic Plc, Boston Scientific Corporation, Edward Lifesciences, AngioDynamics, Inc. and LeMaitre Vascular, Inc. among others.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Deliverables
• 1.2 Study Assumptions
• 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Increasing Prevalence of Cardiovascular Diseases and Ageing Population
  • 4.2.2 Growing Demand for Minimally Invasive Surgeries and Advancements in Technologies
• 4.3 Market Restraints
  • 4.3.1 Stringent Regulatory Procedures
  • 4.3.2 Availability of Alternative Treatments
• 4.4 Porter's Five Force Analysis
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers/Consumers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

• 5.1 By Product
  • 5.1.1 Embolectomy Balloon Catheter
  • 5.1.2 Catheter Directed Thrombolysis Devices
  • 5.1.3 Percutaneous Thrombectomy Devices
  • 5.1.4 Inferior Vena cava Filters
  • 5.1.5 Neurovascular Embolectomy Devices
• 5.2 By End-User
  • 5.2.1 Hospitals
  • 5.2.2 Ambulatory Surgical Centers
  • 5.2.3 Others
• 5.3 Geography
  • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
  • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
  • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
  • 5.3.4 Middle-East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle-East and Africa
  • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

• 6.1 Company Profiles
  • 6.1.1 Medtronic Plc
  • 6.1.2 Boston Scientific Corporation
  • 6.1.3 Edward Lifesciences
  • 6.1.4 Teleflex Incorporated
  • 6.1.5 Johnson & Johnson
  • 6.1.6 LeMaitre Vascular, Inc.
  • 6.1.7 Strub Medical GmbH & Co. KG
  • 6.1.8 AngioDynamics
  • 6.1.9 iVascular SLU
  • 6.1.10 Cook Group Incorporated

7 MARKET OPPORTUNITIES AND FUTURE TRENDS